Attached files

file filename
EX-3.1 - EXHIBIT 3.1 - SEQUENOM INCexhibit31.htm
EX-99.1 - EXHIBIT 99.1 - SEQUENOM INCexhibit991.htm


 
 
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 
 
 
 
 
FORM 8-K
 
 
 
 
 
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 17, 2015
 
 
 
 
 
 
 
SEQUENOM, INC.
(Exact Name of Registrant as Specified in Charter)
 
 
 
 
 
 

DELAWARE
 
000-29101
 
77-0365889
(State or Other Jurisdiction
of Incorporation)
 
(Commission File Number)
 
(I.R.S. Employer
Identification No.)
3595 JOHN HOPKINS COURT
SAN DIEGO, CALIFORNIA 92121
(Address of Principal Executive Offices)
(858) 202-9000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 





Item 5.07.    Submission of Matters to a Vote of Security Holders.

On June 17, 2015, we held our 2015 Annual Meeting of Stockholders (the “Annual Meeting”) at which our stockholders (i) elected Kenneth F. Buechler, Myla Lai-Goldman, Richard A. Lerner, Ronald M. Lindsay, Catherine J. Mackey, David Pendarvis, Charles P. Slacik, Dirk van den Boom and William Welch as directors to hold office until the annual meeting of stockholders in 2016; (ii) approved an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 185,000,000 to 275,000,000 shares; (iii) approved, on an advisory basis, the compensation of our named executive officers, as disclosed in our proxy statement; and (iv) ratified the selection by our Audit Committee (the “ Audit Committee”) of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015.

We had 118,082,585 shares of common stock outstanding and entitled to vote as of the close of business on April 21, 2015, the record date for the Annual Meeting. At the Annual Meeting, 99,604,376 shares of common stock were present in person or represented by proxy for the four proposals indicated above. The following sets forth detailed information regarding the results of the voting at the Annual Meeting:

Proposal 1: The election of Kenneth F. Buechler, Myla Lai-Goldman, Richard A. Lerner, Ronald M. Lindsay, Catherine J. Mackey, David Pendarvis, Charles P. Slacik, Dirk van den Boom and William Welch as directors to hold office until the annual meeting of stockholders in 2016.

Director
Votes For
Votes Withheld
Broker Non-Votes
Kenneth F. Buechler
56,092,949
3,434,695
40,076,732
Myla Lai-Goldman
56,337,978
3,189,666
40,076,732
Richard A. Lerner
34,667,774
24,859,870
40,076,732
Ronald M. Lindsay
55,031,643
4,496,001
40,076,732
Catherine J. Mackey
56,560,915
2,966,729
40,076,732
David Pendarvis
56,248,616
3,279,028
40,076,732
Charles P. Slacik
56,517,529
3,010,115
40,076,732
Dirk van den Boom
55,123,847
4,403,797
40,076,732
William Welch
56,211,757
3,315,887
40,076,732

Proposal 2: To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 185,000,000 to 275,000,000 shares. The Certificate of Amendment to our Restated Certificate of Incorporation is attached as Exhibit 3.1 to this current report.

Votes For
Votes Against
Abstentions
Broker Non-Votes
83,014,519
15,820,002
769,855
N/A

Proposal 3: To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in our proxy statement.

Votes For
Votes Against
Abstentions
Broker Non-Votes
53,131,650
5,204,059
1,191,935
40,076,732

Proposal 4: To ratify the selection by our Audit Committee of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015.

Votes For
Votes Against
Abstentions
Broker Non-Votes
95,545,377
3,079,318
979,681
N/A


2



Item 8.01.    Other Events.

On June 18, 2015, we issued a press release announcing the election of Catherine J. Mackey to our Board of Directors. A copy of the press release is attached as Exhibit 99.1 to this current report.

Item 9.01.    Financial Statements and Exhibits.

(d) Exhibits

3.1    Certificate of Amendment to Restated Certificate of Incorporation.

99.1
Press release dated June 18, 2015 announcing the election of Catherine J. Mackey to our Board of Directors.




3



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
SEQUENOM, INC.
 
 
 
 
Date: June 18, 2015
By:
 
/s/ Jeffrey D. Linton
 
 
 
Jeffrey D. Linton
 
 
 
Senior Vice President, General Counsel & Secretary
 




4